Windtree Therapeutics, Inc.
Q2 2024 13F Holders
Symbol
WINT
CUSIP
97382D501
Type
Equity
Class
COM NEW
Num filings
6
Total reported value, excl. options
$4.87 k
Compare 2024 Q2 to
2024 Q4
2024 Q3
Manager
Report Date
Value ($000)
Shares
Option Type